Masterson, L.A., Spanswick, V.J., Hartley, J.A., Begent, R.H., Howard, P.W. and Thurston, D.E. (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. Bioorganic and Medicinal Chemistry Letters, 16 (2). pp. 252-256. 10.1016/j.bmcl.2005.10.017.
Full text not available from this repository.
The design, synthesis and evaluation of four novel pyrrolo[2,1-c][1,4] benzodiazepine (PBD) prodrugs (1a,b and 2a,b; Fig. 1) for potential use in carboxypeptidase G2 (CPG2)-based antibody-directed enzyme prodrug therapy (ADEPT) is reported. Although all four prodrugs were shown to be less cytotoxic than the released parent PBDs 3 and 4, the urea prodrugs 1b and 2b were found to be too unstable for use in ADEPT, whereas carbamates 1a and 2a are both stable in an aqueous environment and are good substrates for CPG2.
|Uncontrolled Keywords:||ADEPT; CPG2; PBD; Prodrug; Pyrrolo[2,1-c][1,4]benzodiazepines|
|Departments, units and centres:||Department of Pharmaceutical and Biological Chemistry > Department of Pharmaceutical and Biological Chemistry|
|Journal or Publication Title:||Bioorganic and Medicinal Chemistry Letters|
|Deposited By:||Library Staff|
|Deposited On:||08 Mar 2012 10:27|
|Last Modified:||08 Mar 2012 10:27|
Item downloaded times since 08 Mar 2012 10:27.
Repository Staff Only: Item control page
School of Pharmacy Staff Only: Edit a copy to replace this item